Advertisement
MYO vs RDNT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYO is a Hold and RDNT is a StrongBuy.
MYO in -7.69% downward trend, falling for three consecutive days on November 02, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MYO declined for three days, in 284 of 316 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
MYO moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MYO crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for MYO entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MYO's RSI Indicator exited the oversold zone, 35 of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 60 cases where MYO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on MYO as a result. In 58 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for MYO just turned positive on November 03, 2026. Looking at past instances where MYO's MACD turned positive, the stock continued to rise in 30 of 40 cases over the following month. The odds of a continued upward trend are 75%.
Following a +8.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where MYO advanced for three days, in 197 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
MYO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.085) is normal, around the industry mean (4.338). P/E Ratio (-3.500) is within average values for comparable stocks, (1.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (1.262) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. MYO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
RDNT in upward trend: 10-day moving average moved above 50-day moving average on November 04, 2026
The 10-day moving average for RDNT crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on RDNT as a result. In 61 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for RDNT just turned positive on October 22, 2026. Looking at past instances where RDNT's MACD turned positive, the stock continued to rise in 43 of 55 cases over the following month. The odds of a continued upward trend are 78%.
RDNT moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +9.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in 230 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
RDNT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for RDNT entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.601) is normal, around the industry mean (66.911). RDNT's P/E Ratio (-300.038) is considerably lower than the industry average of (2.514). Projected Growth (PEG Ratio) (0.260) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.567) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating fairly steady price growth. RDNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MYO | RDNT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 56 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 29 Undervalued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 36 | |
SMR RATING 1..100 | 99 | 91 | |
PRICE GROWTH RATING 1..100 | 42 | 43 | |
P/E GROWTH RATING 1..100 | 87 | 82 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RDNT's Valuation (1) in the Medical Or Nursing Services industry is in the same range as MYO (29) in the Medical Distributors industry. This means that RDNT’s stock grew similarly to MYO’s over the last 12 months.
RDNT's Profit vs Risk Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for MYO (100) in the Medical Distributors industry. This means that RDNT’s stock grew somewhat faster than MYO’s over the last 12 months.
RDNT's SMR Rating (91) in the Medical Or Nursing Services industry is in the same range as MYO (99) in the Medical Distributors industry. This means that RDNT’s stock grew similarly to MYO’s over the last 12 months.
MYO's Price Growth Rating (42) in the Medical Distributors industry is in the same range as RDNT (43) in the Medical Or Nursing Services industry. This means that MYO’s stock grew similarly to RDNT’s over the last 12 months.
RDNT's P/E Growth Rating (82) in the Medical Or Nursing Services industry is in the same range as MYO (87) in the Medical Distributors industry. This means that RDNT’s stock grew similarly to MYO’s over the last 12 months.
| MYO | RDNT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 78% | 2 days ago 61% |
| Stochastic ODDS (%) | 2 days ago 70% | 2 days ago 73% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 75% | 2 days ago 78% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 89% | 2 days ago 80% |
| Advances ODDS (%) | 2 days ago 78% | 2 days ago 74% |
| Declines ODDS (%) | 4 days ago 90% | 4 days ago 73% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 64% |
| Aroon ODDS (%) | 2 days ago 88% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MYO’s FA Score shows that 1 FA rating(s) are green while RDNT’s FA Score has 1 green FA rating(s).
- MYO’s FA Score: 1 green, 4 red.
- RDNT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MYO’s TA Score shows that 6 TA indicator(s) are bullish while RDNT’s TA Score has 5 bullish TA indicator(s).
- MYO’s TA Score: 6 bullish, 4 bearish.
- RDNT’s TA Score: 5 bullish, 5 bearish.
Price Growth
MYO (@Medical/Nursing Services) experienced а +3.17% price change this week, while RDNT (@Medical Specialties) price change was +9.14% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -6.73%. For the same industry, the average monthly price growth was -8.65%, and the average quarterly price growth was -7.26%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -9.05%. For the same industry, the average monthly price growth was -8.17%, and the average quarterly price growth was +36.11%.
Reported Earning Dates
MYO is expected to report earnings on Nov 09, 2026.
RDNT is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Medical/Nursing Services (-6.73% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-9.05% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GDXJ | 104.24 | 9.15 | +9.62% |
| VanEck Junior Gold Miners ETF (GDXJ) | |||
| FFGX | 32.45 | 0.55 | +1.72% |
| Fidelity Fundamental Global ex-U.S. ETF | |||
| FDHY | 47.87 | 0.23 | +0.48% |
| Fidelity Enhanced High Yield ETF (FDHY) | |||
| BGRO | 39.39 | -0.44 | -1.11% |
| iShares Large Cap Growth Active ETF (BGRO) | |||
| AAOX | 2.73 | -0.47 | -14.82% |
| Tradr 2X Long AAOI Daily ETF (AAOX) | |||